000182289 001__ 182289
000182289 005__ 20240229145715.0
000182289 0247_ $$2doi$$a10.3389/fonc.2022.870431
000182289 037__ $$aDKFZ-2022-02546
000182289 082__ $$a610
000182289 1001_ $$aHaun, Markus W.$$b0
000182289 245__ $$aNegotiating decisions on aggressive cancer care at end-of-life between patients, family members, and physicians – A qualitative interview study
000182289 260__ $$aLausanne$$bFrontiers Media$$c2022
000182289 3367_ $$2DRIVER$$aarticle
000182289 3367_ $$2DataCite$$aOutput Types/Journal article
000182289 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1666940832_11984
000182289 3367_ $$2BibTeX$$aARTICLE
000182289 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000182289 3367_ $$00$$2EndNote$$aJournal Article
000182289 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000182289 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000182289 7001_ $$aWildenauer, Alina$$b1
000182289 7001_ $$aHartmann, Mechthild$$b2
000182289 7001_ $$aBleyel, Caroline$$b3
000182289 7001_ $$0P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab$$aBecker, Nikolaus$$b4$$udkfz
000182289 7001_ $$aJäger, Dirk$$b5
000182289 7001_ $$aFriederich, Hans-Christoph$$b6
000182289 7001_ $$aTönnies, Justus$$b7
000182289 773__ $$0PERI:(DE-600)2649216-7$$a10.3389/fonc.2022.870431$$gVol. 12, p. 870431$$p870431$$tFrontiers in oncology$$v12$$x2234-943X$$y2022
000182289 909CO $$ooai:inrepo02.dkfz.de:182289$$pVDB
000182289 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1573258b58c33f1922ca9719d0c8c4ab$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000182289 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000182289 9141_ $$y2022
000182289 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-01-27
000182289 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-27
000182289 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-27
000182289 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-01-27
000182289 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-01-27
000182289 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT ONCOL : 2021$$d2022-11-08
000182289 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-08
000182289 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-08
000182289 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-05-11T13:25:45Z
000182289 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-05-11T13:25:45Z
000182289 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-05-11T13:25:45Z
000182289 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-08
000182289 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-08
000182289 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-08
000182289 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bFRONT ONCOL : 2021$$d2022-11-08
000182289 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000182289 980__ $$ajournal
000182289 980__ $$aVDB
000182289 980__ $$aI:(DE-He78)C020-20160331
000182289 980__ $$aUNRESTRICTED